Literature DB >> 32614399

Treatment Recommendations for Persistent Smell and Taste Dysfunction Following COVID-19-The Coming Deluge.

Joshua M Levy1.   

Abstract

Entities:  

Year:  2020        PMID： 32614399      PMCID： PMC7775865          DOI： 10.1001/jamaoto.2020.1378

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN： 2168-6181            Impact factor:   6.223


× No keyword cloud information.
  9 in total

1.  Treatment strategies for postviral olfactory dysfunction: A systematic review.

Authors:  Samuel N Helman; Jonah Adler; Aria Jafari; Sasha Bennett; Jackson R Vuncannon; Ashley C Cozart; Sarah K Wise; Merin E Kuruvilla; Joshua M Levy
Journal:  Allergy Asthma Proc       Date:  2022-03-01       Impact factor: 2.587

Review 2.  The Prevalence and Pathophysiology of Chemical Sense Disorder Caused by the Novel Coronavirus.

Authors:  Sareesh Naduvil Narayanan; Pooja Shivappa; Sreeshma Padiyath; Anand Bhaskar; Yan Wa Li; Tarig Hakim Merghani
Journal:  Front Public Health       Date:  2022-06-06

3.  Regarding Use of Topical Steroids in Patients With COVID-19-Associated Olfactory Loss-Reply.

Authors:  Joshua M Levy
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2021-01-01       Impact factor: 6.223

4.  Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: a cohort study.

Authors:  Hui Qi Mandy Tan; Alfonso Luca Pendolino; Peter J Andrews; David Choi
Journal:  BMJ Open       Date:  2022-01-25       Impact factor: 2.692

5.  Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases.

Authors:  Claudia Cristina Ferreira Vasconcelos; Mariana Beiral Hammerle; Deborah Santos Sales; Fernanda Cristina Rueda Lopes; Patricia Gomes Pinheiro; Elisa Gutman Gouvea; Manuella Caroline Dutra Frazão Alves; Tayane Vasconcellos Pereira; Sergio Luis Schmidt; Regina Maria Papais Alvarenga; Karina Lebeis Pires
Journal:  J Neurovirol       Date:  2022-04-02       Impact factor: 2.643

6.  Efficacy and safety of acupuncture in the treatment of the sequela of olfactory disorders after infection with COVID-19: A protocol for systematic review and meta analysis.

Authors:  Chao Tang; Xiaoqin He; Wenkang Fu; Yaxin Du; Yuxin Huang; Lu Liu; Wanning Lan; Runjun Luo; Yue Liu
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

7.  Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study.

Authors:  Sven Saussez; Luigi Angelo Vaira; Carlos M Chiesa-Estomba; Serge-D Le Bon; Mihaela Horoi; Giovanna Deiana; Marzia Petrocelli; Philippe Boelpaep; Giovanni Salzano; Mohamad Khalife; Stephane Hans; Giacomo De Riu; Claire Hopkins; Jerome R Lechien
Journal:  Pathogens       Date:  2021-06-04

Review 8.  Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients.

Authors:  Yasuo Okada; Ken Yoshimura; Shuji Toya; Makoto Tsuchimochi
Journal:  Jpn Dent Sci Rev       Date:  2021-07-09

Review 9.  The Oral Complications of COVID-19.

Authors:  Xinxuan Zhou; Jiajia Dong; Qiang Guo; Mingyun Li; Yan Li; Lei Cheng; Biao Ren
Journal:  Front Mol Biosci       Date:  2022-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.